The estimated Net Worth of Simon X Benito is at least $197 Thousand dollars as of 15 May 2024. Mr. Benito owns over 2,166 units of Inovio Pharmaceuticals Inc stock worth over $65,657 and over the last 20 years he sold INO stock worth over $0. In addition, he makes $131,251 as Independent Chairman of the Board at Inovio Pharmaceuticals Inc.
Simon has made over 20 trades of the Inovio Pharmaceuticals Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 2,166 units of INO stock worth $14,187 on 15 May 2024.
The largest trade he's ever made was buying 40,000 units of Inovio Pharmaceuticals Inc stock on 10 March 2015 worth over $72,400. On average, Simon trades about 3,083 units every 72 days since 2005. As of 15 May 2024 he still owns at least 10,024 units of Inovio Pharmaceuticals Inc stock.
You can see the complete history of Mr. Benito stock trades at the bottom of the page.
Simon X. Benito serves as Independent Chairman of the Board of the Company. He has served on our Board since December 2003 and qualifies to serve on our Board as he brings to our Board formal accounting and financial training and expertise, significant public company board experience, senior management experience in the health care industry, and important industry contacts. Prior to his retirement, Mr. Benito had a successful and extensive career serving several multinational corporations in senior executive positions, including 25 years at Merck & Company, Inc. His most recent positions included Senior Vice President, Merck Vaccine Division; Executive Vice President, Merck-Medco Managed Care; and Executive Director and Vice President, Merck Human Health, Japan. In addition, Mr. Benito was a Fellow of the Institute of Chartered Accountants in England and Wales for over 30 years until his retirement in 1999. Since April 2005, Mr. Benito has served as a director of DURECT Corporation, a publicly traded specialty pharmaceutical company.
As the Independent Chairman of the Board of Inovio Pharmaceuticals Inc, the total compensation of Simon Benito at Inovio Pharmaceuticals Inc is $131,251. There are 10 executives at Inovio Pharmaceuticals Inc getting paid more, with Jong Kim having the highest compensation of $2,588,530.
Simon Benito is 75, he's been the Independent Chairman of the Board of Inovio Pharmaceuticals Inc since 2019. There are no older and 14 younger executives at Inovio Pharmaceuticals Inc.
Simon's mailing address filed with the SEC is 660 W. GERMANTOWN PIKE, SUITE 110, , PLYMOUTH MEETING, PA, 19462.
Over the last 20 years, insiders at Inovio Pharmaceuticals Inc have traded over $23,656,819 worth of Inovio Pharmaceuticals Inc stock and bought 1,958,377 units worth $5,174,071 . The most active insiders traders include Austin W & Greenhouse David..., Jong Joseph Kim, and Felix Theeuwes. On average, Inovio Pharmaceuticals Inc executives and independent directors trade stock every 22 days with the average trade being worth of $745,390. The most recent stock trade was executed by Michael John Sumner on 30 June 2024, trading 2,917 units of INO stock currently worth $19,106.
inovio is revolutionizing the fight against cancer and infectious diseases. our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. with an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. partners and collaborators include roche, medimmune, university of pennsylvania, darpa, drexel university, nih, hiv vaccines trial network, national cancer institute, u.s. military hiv research program, and university of manitoba. for more information, visit www.inovio.com.
Inovio Pharmaceuticals Inc executives and other stock owners filed with the SEC include: